📊 CELC Key Takeaways
Investment Thesis
Celcuity is a pre-revenue or severely revenue-challenged medical laboratory company burning substantial cash with negative operating income of -$123M and negative free cash flow of -$117.1M. Despite adequate liquidity ($74.3M cash), the company is not generating any revenue to support operations, indicating either a business model failure or extremely early-stage development without demonstrated commercialization capability.
CELC Strengths
- Strong current ratio of 12.26x indicates sufficient short-term liquidity to cover operational burn
- Cash position of $74.3M provides runway for operations, though burn rate suggests limited duration
- Recent Form 4 filings show 3 insider transactions indicating some management activity
CELC Risks
- Zero or near-zero revenue with massive operating losses (-$123M) signals fundamental business model issues or failed commercialization
- Negative free cash flow of -$117.1M represents severe cash burn that will rapidly deplete the $74.3M cash reserve (approximately 7.7 months of runway)
- Negative ROE of -107.8% and ROA of -26.5% indicate shareholder value destruction; long-term debt of $137.2M creates leverage risk when combined with zero revenue generation
- No profitability metrics available (N/A margins) reflects inability to achieve gross profit, suggesting operational failure to generate positive contribution margins
Key Metrics to Watch
- Quarterly revenue generation and path to positive gross profit
- Operating cash burn rate and cash runway remaining
- Long-term debt refinancing obligations and ability to service debt without revenue
CELC Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 12.26x current ratio provides a solid financial cushion.
CELC Profitability Ratios
CELC vs Healthcare Sector
How Celcuity Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CELC Balance Sheet & Liquidity
CELC 5-Year Financial Trend
5-Year Trend Summary: Celcuity Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-2.69 indicates the company is currently unprofitable.
CELC Growth Metrics (YoY)
CELC Capital Allocation
CELC SEC Filings
Access official SEC EDGAR filings for Celcuity Inc. (CIK: 0001603454)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CELC
What is the AI rating for CELC?
Celcuity Inc. (CELC) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CELC's key strengths?
Strong current ratio of 12.26x indicates sufficient short-term liquidity to cover operational burn. Cash position of $74.3M provides runway for operations, though burn rate suggests limited duration.
What are the risks of investing in CELC?
Zero or near-zero revenue with massive operating losses (-$123M) signals fundamental business model issues or failed commercialization. Negative free cash flow of -$117.1M represents severe cash burn that will rapidly deplete the $74.3M cash reserve (approximately 7.7 months of runway).
What is CELC's revenue and growth?
Celcuity Inc. reported revenue of N/A.
Does CELC pay dividends?
Celcuity Inc. does not currently pay dividends.
Where can I find CELC SEC filings?
Official SEC filings for Celcuity Inc. (CIK: 0001603454) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CELC's EPS?
Celcuity Inc. has a diluted EPS of $-2.81.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.